Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$47.15 +0.18 (+0.38%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Other Accumulated Expenses (2010 - 2026)

Updated

Rigel Pharmaceuticals (RIGL) posted Other Accumulated Expenses of $7.95 million for Q2 2026, down 7.5% from $8.59 million a year earlier and down 17.8% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Other Accumulated Expenses (2010 - 2026) Analysis & Trends

At the end of FY2025, Rigel Pharmaceuticals' Other Accumulated Expenses came in at $11.47 million, down 2.4% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
  • In prior years, Rigel Pharmaceuticals' Other Accumulated Expenses was $11.75 million in FY2024 (+120.3%), $5.33 million in FY2023 (-17.7%), $6.49 million in FY2022 (-52.0%) and $13.51 million in FY2021 (+22.6%).
  • The Q2 2026 figure stands as the lowest quarterly Other Accumulated Expenses since Q1 2025.
  • On a year-over-year basis, Other Accumulated Expenses increased in five of the last eight quarters, with growth averaging 38.8%.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2024, with growth of 120.3%; the weakest was Q3 2023, with a decline of 71.4%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $9.67 million (Q1 2026), $11.47 million (Q4 2025) and $8.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Rigel Pharmaceuticals 880.76 Mn 346.64 Mn 70.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.95 Mn
Mar 31, 2026 9.67 Mn
Dec 31, 2025 11.47 Mn
Sep 30, 2025 8.94 Mn
Jun 30, 2025 8.59 Mn
Mar 31, 2025 7.44 Mn
Dec 31, 2024 11.75 Mn
Sep 30, 2024 9.97 Mn
Jun 30, 2024 5.93 Mn
Mar 31, 2024 5.44 Mn
Dec 31, 2023 5.33 Mn
Sep 30, 2023 5.03 Mn
Jun 30, 2023 5.70 Mn
Mar 31, 2023 5.62 Mn
Dec 31, 2022 6.49 Mn
Sep 30, 2022 17.60 Mn
Jun 30, 2022 16.89 Mn
Mar 31, 2022 16.51 Mn
Dec 31, 2021 13.51 Mn
Sep 30, 2021 13.49 Mn
API Access

Rigel Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RIGL&period=max&api_key=YOUR_API_KEY